این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
جمعه 21 آذر 1404
Iranian Journal of Blood and Cancer
، جلد ۱۰، شماره ۱، صفحات ۹-۱۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Recombinant Human Erythropoietin in Children with Solid Tumors and Chemotherapy-induced Anemia
چکیده انگلیسی مقاله
Background: In patients undergoing chemotherapy for cancer, anemia is part of the progression of the disease. Considering the effects of anemia on quality of life of the patients, the prevention and treatment of chemotherapy-induced anemia is crucial. This study was aimed to evaluate the efficacy of recombinant human erythropoietin in reducing the need for blood transfusion in children with solid tumors receiving chemotherapy. Methods: In a clinical trial, 57 children referred to the pediatric centre of Tabriz University of Medical Sciences with a diagnosis of solid tumor were randomly assigned into two groups. The intervention group (n=29) received recombinant human erythropoietin (rHuEPO) at a dose of 450 IU/kg subcutaneously once a week for 12 weeks, and the control group (n=28) received no intervention in this regard. Hemoglobin levels were analysed at the beginning and end of the study. The need for blood transfusion was also assessed in the patients. Results: The mean Hb at the beginning of the study was 8.85±1.01 and 8.98±0.11 g in the intervention and control groups, respectively. The mean Hb at the end of the study was 9.78±0.32 g/dl in the intervention group and 7.79±0.24 g/dl in the control group. Hb level was significantly higher in the intervention group at the end of the 12 weeks of treatment with rHuEPO than in the control group (P=0.001). Conclusion: Based on the results of this study, rHuEPO administration seems to be beneficial in the prevention and treatment of chemotherapy-induced anemia in children with solid tumors and reduces the amount of blood transfusion in these patients.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
| Amir Ataolah Hiradfar
Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
| Azim Rezamand
Department of Pediatric, Tabriz University of Medical Sciences, Tabriz, Iran.
| Matin Pourghasem
Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
| Sepideh Karkon Shayan
Students' Research Committee, Gonabad University of Medical Science, Gonabad, Iran.
| Behnaz Ghamari
Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
| Farid Karkon Shayan
Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
نشانی اینترنتی
http://ijbc.ir/browse.php?a_code=A-10-352-1&slc_lang=en&sid=1
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
Pediatric Hematology & Oncology
نوع مقاله منتشر شده
پژوهشی
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات